# TACE Combined With Iodine-125 Seeds Implantation for HCC

> **NCT03322280** · NA · UNKNOWN · sponsor: **Second Affiliated Hospital of Guangzhou Medical University** · enrollment: 270 (estimated)

## Conditions studied

- Hepatocellular Carcinoma
- Portal Vein Occlusion
- Tumor Thrombus

## Interventions

- **PROCEDURE:** TACE combined with iodine-125 seeds implantation
- **PROCEDURE:** TACE

## Key facts

- **NCT ID:** NCT03322280
- **Lead sponsor:** Second Affiliated Hospital of Guangzhou Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-07-01
- **Primary completion:** 2021-09-18
- **Final completion:** 2022-06-30
- **Target enrollment:** 270 (ESTIMATED)
- **Last updated:** 2022-03-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03322280

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03322280, "TACE Combined With Iodine-125 Seeds Implantation for HCC". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03322280. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*